Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Sept 2026 for 10x Genomics, Inc., €395k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Shehnaaz Suliman: trading record in brief
All filings by Shehnaaz Suliman on record concern 10x Genomics, Inc. Over a trading history stretching from 16 June 2026 to 22 September 2026, the count stands at 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 22 September 2026, the filings show a transaction worth €395k in 10x Genomics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Shehnaaz Suliman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
5,723 shares@ US$79.10Class A CommonSEC144:0001968582-26-001003
2,207 shares@ US$65.120.0017% mcap43.7% of flowClass A CommonSEC144:0001968582-26-000871
5,723 shares@ US$32.220.0025% mcap100.0% of flowClass A CommonSEC144:0001968582-26-000625
3 of 3 declarations
